Shandong Announces Retail Price Caps For 33 Drugs, 13 Synthetic
This article was originally published in PharmAsia News
Shandong province’s commodity price bureau has newly announced retail price caps for 33 drugs, the majority of which common medicines, to be effective from Oct. 15.
You may also be interested in...
Amneal has become the first company to secure US approval for, and to launch, a generic alternative to Merck & Co’s top-selling, off-patent NuvaRing contraceptive device in the US. Other generics developers appear to be several months behind.
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.